查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830956

近距离放射治疗设备市场

Brachytherapy Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

近距离放射治疗设备市场预计将从 2024 年的 3.4357 亿美元增加到 2031 年的 5.342 亿美元，2025 年至 2031 年的复合年增长率预计为 6.7%。

分析师观点

近距离放射治疗，又称为内放射治疗 (IRT)，是指将放射性装置（例如粒子、带状物、导线、针头、胶囊、球囊或导管）放置在肿瘤附近，以释放集中剂量的放射线。这种方法可以有效地破坏和缩小肿瘤。与其他放射疗法不同，近距离放射治疗允许更高的放射剂量，同时最大限度地减少对邻近器官的损害。癌症发生率的上升极大地推动了近距离放射治疗设备市场的成长。此外，技术的进步和内放射治疗在癌症治疗中的应用日益广泛也促进了市场的扩张。然而，近距离放射治疗的相关风险以及熟练技术人员的短缺对市场成长构成了挑战。

市场概况

乳癌、摄护腺癌和子宫颈癌等癌症发生率的不断上升是推动近距离放射治疗设备市场发展的关键因素。根据世界卫生组织 (WHO) 2024 年 2 月发布的资料，2022 年全球报告约有 2,000 万例新发癌症病例和 970 万例癌症死亡病例。其中，乳癌最常见，女性确诊病例达 230 万例。摄护腺癌和大肠癌分别是男性第二大和第三大常见癌症。近距离放射治疗设备通常用于有效治疗妇科癌症、摄护腺癌、乳癌和其他各种癌症。这些设备包括含有放射性物质的导线、粒子或棒，被植入肿瘤附近，以便在特定距离内发射辐射。

此外，与其他放射疗法相比，近距离放射治疗通常速度更快，副作用更少。爱思唯尔于2023年6月发表的一项研究，利用大型多机构资料库，比较了近距离放射治疗与外照射放射治疗 (EBRT) 的结果，结果显示，与EBRT相比，近距离放射治疗具有更高的生存率和更低的远处转移发生率。这项发现至关重要，有望推动近距离放射治疗成为中高风险前列腺癌患者经济有效的治疗方法。

随着全球癌症盛行率持续上升，近距离放射治疗作为一种广泛可用的治疗选择的需求极大地促进了近距离放射治疗设备市场的成长。

战略洞察

报告细分和范围

「近距离放射治疗设备市场分析」考虑了以下几个部分：产品类型、类型、应用和最终用户。

市场按产品类型细分为粒子、近距离放射治疗后装器和施放器以及电子近距离放射治疗。按类型细分，市场分为高剂量率近距离放射治疗植入物和低剂量率近距离放射治疗植入物。市场也按应用细分为乳癌、子宫颈癌、摄护腺癌、肺癌等。

根据最终用户，市场分为医院和专科诊所、门诊手术中心和其他。

全球近距离放射治疗设备市场报告的范围包括北美（美国、加拿大和墨西哥）、欧洲（德国、法国、义大利、英国、西班牙和欧洲其他地区）、亚太地区（中国、日本、印度、澳洲、韩国和亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋和中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲（巴西、阿根廷和南美洲和其他地区）。

按产品类型分類的见解

根据产品类型，近距离放射治疗设备市场分为粒子、近距离放射治疗后装器和施用器以及电子近距离放射治疗。近距离放射治疗后装置和施用器细分市场在2022年占据最大市场份额，预计在2022年至2030年期间的复合年增长率最高。

按类型分類的见解

市场按类型分为高剂量近距离放射治疗植入物和低剂量率近距离放射治疗植入物。低剂量率近距离放射治疗植入物在2022年占据了近距离放射治疗设备市场的较大份额，预计在2022年至2030年期间将以更快的复合年增长率增长。

按应用程式洞察

近距离放射治疗设备市场按应用细分为乳癌、子宫颈癌、摄护腺癌、肺癌等。前列腺癌领域在2022年占据了最大的市场份额，预计在2022年至2030年期间将实现最高的复合年增长率。

最终使用者的见解

按最终用户划分，市场分为医院和专科诊所、门诊手术中心和其他类型。 2022年，医院占据了最大的市场份额，这归因于与其他手术中心相比，医院拥有更优越的设施和更熟练的医生，可以进行微创手术。

区域分析

从地理来看，市场细分为北美、亚太地区、欧洲、中东和非洲以及南美和中美。 2022年，北美在近距离放射治疗设备市场收入方面领先，主要由美国推动。这种主导地位源自于多种因素，包括该地区女性乳癌和男性前列腺癌发生率的上升。根据泛美卫生组织 (PAHO) 的数据，2020年美洲约有400万人被诊断出罹患癌症，预计到2040年将增加约60%。

此外，BD、Isoray Inc. 和 Elekta 等主要市场参与者的加入，以及先进近距离放射治疗设备的供应，为市场成长带来了巨大的机会。例如，2021 年 7 月，GenesisCare 从 Elekta 收购了 27 台 Flexitron 近距离放射治疗后装系统及服务协议，从而扩展了其近距离放射治疗服务，使其能够掌握最新技术，并为其在美国各地中心的患者提供高品质的护理。

近距离放射治疗设备市场报告范围：产业发展与未来机会：近距离放射治疗设备市场预测可以帮助利害关係人规划其成长策略。根据公司新闻稿，全球市场领导企业的几项策略发展重点如下：

2023年10月，医科达（Elekta）宣布透过资产收购的方式，从iCAD公司收购Xoft业务。此次收购Xoft Axxent电子近距离放射治疗（eBx）系统以及员工转移旨在增强公司提供的癌症治疗方案和电子近距离放射治疗技术。 2023年7月，CIVCO Radiotherapy公司在2022年10月23日至26日于德克萨斯州圣安东尼奥举行的美国放射肿瘤学会（ASTRO）年会上宣布与专门生产患者定位和固定设备的公司Qfix建立合作伙伴关係。 2022年7月，BEBIG Medical公司收购了德国公司Wolf-Medizintechnik GmbH（WOmed），该公司在全球提供先进的X射线治疗和新开发的术中放射治疗产品。此次收购旨在增强BEBIG Medical在癌症放射治疗领域的产品组合。

2020年12月，瓦里安医疗系统公司推出了四套新型近距离放射治疗施放器，用于针对阴道、子宫颈、子宫、子宫内膜和直肠的高动态范围（HDR）近距离放射治疗。这些新型施放器旨在解决尺寸、易用性和MRI成像支援方面的问题，使其更加用户友好，患者使用更加舒适，使临床医生能够在门诊治疗更多患者。近距离放射治疗设备市场报告中介绍的主要公司包括医科达（Elekta）、瓦里安医疗系统公司（Varian Medical Systems, Inc.）、BEBIG Medical、Theragenics Corporation、IsoAid、西门子医疗系统公司（Siemens Healthineers AG）、BXTA、BD、Eckert and Ziegler股份公司以及Perspective Therapyeutics。这些领导企业正致力于扩大和多元化其市场影响力和客户群，以抓住市场商机。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：近距离放射治疗设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：近距离放射治疗设备市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：近距离放射治疗设备市场－全球市场分析

  • 近距离放射治疗设备 - 全球市场概览
  • 近距离放射治疗设备－全球市场及2031年预测

第七章：近距离放射治疗设备市场-收入分析-依产品类型，2021-2031

  • 概述
  • 种子
  • 近距离放射治疗后装器和施放器
  • 电子近距离放射治疗

第 8 章：近距离放射治疗设备市场 - 收入分析 - 按类型，2021-2031 年

  • 概述
  • 高剂量率近距离放射治疗植入物
  • 低剂量率近距离放射治疗植入物

第九章：近距离放射治疗设备市场-收入分析-按应用，2021-2031

  • 概述
  • 乳癌
  • 子宫颈癌
  • 摄护腺癌
  • 肺癌
  • 其他的

第 10 章：近距离放射治疗设备市场 - 收入分析 - 按最终用户，2021-2031 年

  • 概述
  • 医院和专科诊所
  • 门诊手术中心
  • 其他的

第 11 章：近距离放射治疗设备市场 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 13 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 14 章：近距离放射治疗设备市场 - 主要公司简介

  • Elekta
  • Varian Medical Systems, Inc
  • BEBIG Medical
  • Theragenics Corporation
  • IsoAid
  • Siemens Healthineers AG
  • BXTA
  • BD
  • Eckert and Ziegler
  • Perspective Therapeutics

第 15 章：附录

简介目录
Product Code: TIPHE100001169

The brachytherapy devices market is projected to increase from US$ 343.57 million in 2024 to US$ 534.20 million by 2031, with an estimated CAGR of 6.7% from 2025 to 2031.

Analyst Perspective

Brachytherapy, or internal radiation therapy (IRT), involves placing radioactive devices such as seeds, ribbons, wires, needles, capsules, balloons, or tubes close to tumors to deliver concentrated doses of radiation. This method is effective in destroying and reducing tumors. Unlike other radiation therapies, brachytherapy allows for higher radiation doses while minimizing harm to adjacent organs. The rising incidence of cancers significantly drives the growth of the brachytherapy devices market. Furthermore, advancements in technology and the increasing use of IRTs for cancer treatment are also contributing to market expansion. However, the risks associated with brachytherapy and a shortage of skilled technicians pose challenges to market growth.

Market Overview

The growing incidence of cancers, such as breast, prostate, and cervical cancer, is a key factor driving the brachytherapy devices market. According to data released by the World Health Organization (WHO) in February 2024, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were reported worldwide in 2022. Among these, breast cancer was the most prevalent, with 2.3 million cases diagnosed in women. Prostate and colorectal cancers rank as the second and third most common cancers in men, respectively. Brachytherapy devices are commonly utilized to effectively treat gynecologic, prostate, breast, and various other cancers. These devices, which include wires, seeds, or rods containing radioactive materials, are implanted near tumors to deliver radiation over a specific distance.

Additionally, brachytherapy is generally quicker and has fewer side effects compared to other radiation therapies. A study published by Elsevier in June 2023 compared the outcomes of brachytherapy with external beam radiation therapy (EBRT) using a large multi-institutional database, revealing that brachytherapy is associated with better survival rates and a lower incidence of distant cancer metastases compared to EBRT. This finding is crucial and may promote the adoption of brachytherapy as a cost-effective and efficient treatment for patients with intermediate- to high-risk prostate cancer.

As the global cancer prevalence continues to rise, the demand for brachytherapy as a widely accessible treatment option significantly contributes to the growth of the brachytherapy devices market.

Strategic Insights

Report Segmentation and Scope

The "brachytherapy devices market analysis" has been conducted considering the following segments: product type, type, application, and end user.

The market is segmented by product type into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. By type, the market is divided into high-dose rate brachytherapy implants and low-dose rate brachytherapy implants. The market is also segmented by application into breast cancer, cervical cancer, prostate cancer, lung cancer, and others.

By end user, the market is categorized into hospitals and specialty clinics, ambulatory surgical centers, and others.

The scope of the global brachytherapy devices market report includes North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Insights by Product Type

Based on product type, the brachytherapy devices market is divided into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders and applicators segment held the largest market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030.

Insights by Type

The market is categorized by type into high-dose brachytherapy implants and low-dose rate brachytherapy implants. The low-dose rate brachytherapy implant segment accounted for a larger share of the brachytherapy devices market in 2022 and is projected to grow at a faster CAGR from 2022 to 2030.

Insights by Application

The brachytherapy devices market is segmented by application into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022 to 2030.

Insights by End User

By end user, the market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022, attributed to the availability of superior facilities and skilled physicians in hospitals compared to other surgical centers for performing minimally invasive procedures.

Regional Analysis

Geographically, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America led the brachytherapy devices market in terms of revenue in 2022, primarily driven by the US. This dominance is due to several factors, including the rising incidence of breast cancer among women and prostate cancer among men in the region. According to the Pan America Health Organization (PAHO), approximately 4 million people in the Americas were diagnosed with cancer in 2020, with projections indicating a ~60% increase by 2040.

Moreover, the presence of key market players such as BD, Isoray Inc., and Elekta, along with the availability of advanced brachytherapy devices, presents significant opportunities for market growth. For example, in July 2021, GenesisCare expanded its brachytherapy services by acquiring 27 Flexitron brachytherapy afterloader systems and service agreements from Elekta, enabling them to stay updated with the latest technology and provide high-quality care to patients across their centers in the US.

Brachytherapy Devices Market Report ScopeIndustry Developments and Future Opportunities:The brachytherapy devices market forecast can assist stakeholders in planning their growth strategies. According to company press releases, several strategic developments by leading players in the global market are highlighted below:

In October 2023, Elekta announced the acquisition of the Xoft business from iCAD, Inc. through an asset acquisition. This acquisition of the Xoft Axxent Electronic Brachytherapy (eBx) System, along with the transfer of employees, aims to enhance the range of cancer treatment options and electronic brachytherapy technology offered by the company.In July 2023, CIVCO Radiotherapy announced a partnership with Qfix, a company specializing in devices for patient positioning and immobilization, during the American Society for Radiation Oncology (ASTRO) Annual Meeting held from October 23-26, 2022, in San Antonio, Texas.In July 2022, BEBIG Medical acquired Wolf-Medizintechnik GmbH (WOmed), a German company that provides advanced X-ray therapy and newly developed intraoperative radiation therapy products globally. This acquisition aimed to enhance BEBIG Medical's product offerings in radiation therapy for cancer treatment.

In December 2020, Varian Medical Systems, Inc. launched four new brachytherapy applicator sets for HDR brachytherapy targeting the vagina, cervix, uterus, endometrium, and rectum. These new applicators are designed to address size, usability, and MRI imaging support issues, making them more user-friendly and comfortable for patients, thus allowing clinicians to treat more patients on an outpatient basis.Key companies profiled in the brachytherapy devices market report include Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, Eckert and Ziegler, and Perspective Therapeutics. These leading players are focused on expanding and diversifying their market presence and clientele, seizing business opportunities in the market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Brachytherapy Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Brachytherapy Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Brachytherapy Devices Market - Global Market Analysis

  • 6.1 Brachytherapy Devices - Global Market Overview
  • 6.2 Brachytherapy Devices - Global Market and Forecast to 2031

7. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By Product Type, 2021-2031

  • 7.1 Overview
  • 7.2 Seeds
  • 7.3 Brachytherapy Afterloaders and Applicators
  • 7.4 Electronic Brachytherapy

8. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By Type, 2021-2031

  • 8.1 Overview
  • 8.2 High Dose Rate Brachytherapy Implants
  • 8.3 Low Dose Rate Brachytherapy Implants

9. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 9.1 Overview
  • 9.2 Breast Cancer
  • 9.3 Cervical Cancer
  • 9.4 Prostate Cancer
  • 9.5 Lung Cancer
  • 9.6 Others

10. Brachytherapy Devices Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 10.1 Overview
  • 10.2 Hospital and Specialty Clinics
  • 10.3 Ambulatory Surgical Centers
  • 10.4 Others

11. Brachytherapy Devices Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Brachytherapy Devices Market Overview
    • 11.1.2 North America Brachytherapy Devices Market Revenue and Forecasts to 2031
    • 11.1.3 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Product Type
    • 11.1.4 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Type
    • 11.1.5 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Application
    • 11.1.6 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Brachytherapy Devices Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Brachytherapy Devices Market
        • 11.1.7.1.1 United States Brachytherapy Devices Market, by Product Type
        • 11.1.7.1.2 United States Brachytherapy Devices Market, by Type
        • 11.1.7.1.3 United States Brachytherapy Devices Market, by Application
        • 11.1.7.1.4 United States Brachytherapy Devices Market, by End User
      • 11.1.7.2 Canada Brachytherapy Devices Market
        • 11.1.7.2.1 Canada Brachytherapy Devices Market, by Product Type
        • 11.1.7.2.2 Canada Brachytherapy Devices Market, by Type
        • 11.1.7.2.3 Canada Brachytherapy Devices Market, by Application
        • 11.1.7.2.4 Canada Brachytherapy Devices Market, by End User
      • 11.1.7.3 Mexico Brachytherapy Devices Market
        • 11.1.7.3.1 Mexico Brachytherapy Devices Market, by Product Type
        • 11.1.7.3.2 Mexico Brachytherapy Devices Market, by Type
        • 11.1.7.3.3 Mexico Brachytherapy Devices Market, by Application
        • 11.1.7.3.4 Mexico Brachytherapy Devices Market, by End User
  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Brachytherapy Devices Market - Key Company Profiles

  • 14.1 Elekta
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Varian Medical Systems, Inc
  • 14.3 BEBIG Medical
  • 14.4 Theragenics Corporation
  • 14.5 IsoAid
  • 14.6 Siemens Healthineers AG
  • 14.7 BXTA
  • 14.8 BD
  • 14.9 Eckert and Ziegler
  • 14.10 Perspective Therapeutics

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud